LPL Financial
SNDX icon

LPL Financial’s Syndax Pharmaceuticals SNDX Stock Holding History

LPL Financial’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-11,355
Closed -$100K – 3410
2019
Q4 		$100K Buy
+11,355
New +$83.4K ﹤0.01% 3221
2018
Q4 		– Sell
-14,130
Closed -$114K – 3228
2018
Q3 		$114K Buy
14,130
+200
+1% +$1.43K ﹤0.01% 3117
2018
Q2 		$98K Buy
+13,930
New +$137K ﹤0.01% 3107

Other funds holding SNDX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

LPL Financial's SNDX Position: Q1 2020 in Review

LPL Financial sold out of Syndax Pharmaceuticals (SNDX) in Q1 2020, closing a stake of 11,355 shares — an estimated $100K sold.

LPL Financial first reported a position in SNDX in Q2 2018 and held it in 3 quarters. The position peaked at $114K in Q3 2018. 83 funds tracked by Wall St. Rank hold SNDX as of Q1 2020.

  • LPL Financial reported no remaining Syndax Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • LPL Financial sold 11,355 Syndax Pharmaceuticals shares in Q1 2020, an estimated $100K.
  • LPL Financial first reported a position in Syndax Pharmaceuticals in Q2 2018 and held it in 3 quarters.
  • LPL Financial's Syndax Pharmaceuticals position peaked at $114K in Q3 2018.
  • 83 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q1 2020.

Based on LPL Financial's 13F filing for Q1 2020, filed 14 May 2020.